Dr. Swan Swan Leong
Claim this profileOncocare Cancer Centre
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
4 drugs studied
Area of expertise
1Lung Cancer
ALK negative
PD-L1 positive
EGFR negative
2Non-Small Cell Lung Cancer
ALK negative
PD-L1 positive
EGFR negative
Clinical Trials Swan Swan Leong is currently running
More about Swan Swan Leong
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Swan Swan Leong has experience with
- APL-101
- Domvanalimab
- Etrumadenant
- Zimberelimab
Breakdown of trials Swan Swan Leong has run
Non-Small Cell Lung Cancer
MET Fusion
Hemangiopericytoma
Methylation Alteration
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Swan Swan Leong specialize in?
Swan Swan Leong focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved ALK negative patients, or patients who are PD-L1 positive.
Is Swan Swan Leong currently recruiting for clinical trials?
Yes, Swan Swan Leong is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Swan Swan Leong has studied deeply?
Yes, Swan Swan Leong has studied treatments such as APL-101, Domvanalimab, Etrumadenant.
What is the best way to schedule an appointment with Swan Swan Leong?
Apply for one of the trials that Swan Swan Leong is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.